These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 12957725)

  • 21. Factors associated with discharge lipid-lowering drug prescription in patients hospitalized for coronary artery disease (from the Get With the Guidelines database).
    Albert NM; Birtcher KK; Cannon CP; Goff DC; Mulgund J; Liang L; Fonarow GC
    Am J Cardiol; 2008 May; 101(9):1242-6. PubMed ID: 18435951
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of a targeted intervention on lipid-lowering therapy in patients with coronary artery disease in the hospital setting.
    Lacy CR; Suh DC; Barone JA; Bueno M; Moylan D; Swartz C; Kudipudi RV; Kostis JB
    Arch Intern Med; 2002 Feb; 162(4):468-73. PubMed ID: 11863482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug prescription rates in secondary cardiovascular prevention in old age: Do vulnerability and severity of the history of cardiovascular disease matter?
    van Peet PG; Gussekloo J; den Elzen WP; Blom JW; de Waal MW; de Ruijter W
    Scand J Prim Health Care; 2015; 33(4):260-8. PubMed ID: 26683286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. General practitioners' prescribing of lipid-lowering medications for Indigenous and non-Indigenous Australians, 2001-2013.
    Trivedi AN; Pollack AJ; Britt HC; Miller GC; Harrison C; Kelaher MA
    Med J Aust; 2015 Nov; 203(10):407-7.e5. PubMed ID: 26561906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contemporary diagnosis and management of hypercholesterolemia in elderly acute myocardial infarction patients: a population-based study.
    Berger AK; Duval SJ; Armstrong C; Jacobs DR; Luepker RV
    Am J Geriatr Cardiol; 2007; 16(1):15-23. PubMed ID: 17215638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific profile and referral bias of rehabilitated patients after an acute coronary syndrome.
    Cottin Y; Cambou JP; Casillas JM; Ferrières J; Cantet C; Danchin N
    J Cardiopulm Rehabil; 2004; 24(1):38-44. PubMed ID: 14758102
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cracovian program for secondary prevention of ischemic heart disease. Methods of intervention].
    Kawecka-Jaszcz K; Pajak A; Jankowski P
    Przegl Lek; 2003; 60(3):133-5. PubMed ID: 14575012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid-lowering drug use and cardiovascular events after myocardial infarction.
    Klungel OH; Heckbert SR; de Boer A; Leufkens HG; Sullivan SD; Fishman PA; Veenstra DL; Psaty BM
    Ann Pharmacother; 2002 May; 36(5):751-7. PubMed ID: 11978147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Retrospective analysis of the risk factors in patients with ischaemic heart disease hospitalized in the years 1983-1992].
    Pietrzak-Nowacka M; Safranow K; Rulkowska H; Brzosko M; Domański L; Dutkiewicz G; Ławniczak M; Płońska E; Szmatłoch E
    Ann Acad Med Stetin; 2006; 52(2):71-7. PubMed ID: 17633399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Gaps in Adults With Heterozygous Familial Hypercholesterolemia in the United States: Data From the CASCADE-FH Registry.
    deGoma EM; Ahmad ZS; O'Brien EC; Kindt I; Shrader P; Newman CB; Pokharel Y; Baum SJ; Hemphill LC; Hudgins LC; Ahmed CD; Gidding SS; Duffy D; Neal W; Wilemon K; Roe MT; Rader DJ; Ballantyne CM; Linton MF; Duell PB; Shapiro MD; Moriarty PM; Knowles JW
    Circ Cardiovasc Genet; 2016 Jun; 9(3):240-9. PubMed ID: 27013694
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3ST-POL trial: standards of statin use in Poland in the context of the European Society of Cardiology guidelines.
    Sliz D; Mamcarz A; Filipiak KJ; Siebert J; Naruszewicz M
    Pol Arch Med Wewn; 2010 Sep; 120(9):328-33. PubMed ID: 20864905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a retrospective database analysis of adherence to statin therapy and risk of nonfatal ischemic heart disease in daily clinical practice in Italy.
    Corrao G; Conti V; Merlino L; Catapano AL; Mancia G
    Clin Ther; 2010 Feb; 32(2):300-10. PubMed ID: 20206788
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part III. Secondary prevention of ischaemic heart disease after discharge].
    Kawecka-Jaszcz K; Jankowski P; Pajak A; Dubiel J; Maciejewicz J; Piotrowski W; Smielak-Korombel W; Tracz W
    Przegl Lek; 2001; 58(11):964-8. PubMed ID: 11987836
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current standard of care in patients affected by coronary heart disease in Italy: the MC'95 study.
    Magnani B; Dal Palù C; Zanchetti A;
    Ital Heart J; 2002 Feb; 3(2):86-95. PubMed ID: 11926017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improved treatment of coronary heart disease by implementation of a Cardiac Hospitalization Atherosclerosis Management Program (CHAMP).
    Fonarow GC; Gawlinski A; Moughrabi S; Tillisch JH
    Am J Cardiol; 2001 Apr; 87(7):819-22. PubMed ID: 11274933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of a nurse-led lipid-lowering secondary prevention intervention in patients hospitalized for ischemic heart disease: A pilot randomized controlled trial.
    Ruiz-Bustillo S; Ivern C; Badosa N; Farre N; Marco E; Bruguera J; Cladellas M; Enjuanes C; Cainzos-Achirica M; Marti-Almor J; Comin-Colet J
    Eur J Cardiovasc Nurs; 2019 Jun; 18(5):366-374. PubMed ID: 30757908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient factors influencing the prescribing of lipid lowering drugs for primary prevention of cardiovascular disease in UK general practice: a national retrospective cohort study.
    Wu J; Zhu S; Yao GL; Mohammed MA; Marshall T
    PLoS One; 2013; 8(7):e67611. PubMed ID: 23922649
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipid assessment and treatment patterns in hospitalized TIA and ischemic stroke patients.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC;
    J Hosp Med; 2006 Jul; 1(4):214-20. PubMed ID: 17219502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of electronic patient data overview with alerts in primary care increases prescribing of lipid-lowering medications in patients with type 2 diabetes.
    Charles MH; Thomsen JL; Christensen B; Pulleyblank R; Kongstad LP; Olsen KR
    Diabetologia; 2022 Feb; 65(2):286-290. PubMed ID: 34709425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary prevention in patients after hospitalisation due to coronary artery disease: what has changed since 2006?
    Jankowski P; Czarnecka D; Lysek R; Skrzek A; Smaś-Suska M; Mazurek A; Brzozowska-Kiszka M; Wolfshaut-Wolak R; Surowiec S; Bogacki P; Bryniarska-Mirek E; Bryniarski L; Grodecki J; Nessler J; Olszowska M; Podolec P; Kawecka-Jaszcz K; Pająk A
    Kardiol Pol; 2014; 72(4):355-62. PubMed ID: 24408064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.